NIH-funded research R01 grant

Investigating how insulin sensitivity affects metformin's ability to slow aging

Official title: Does insulin sensitivity impact the potential of metformin to slow aging?

Funded at Oklahoma Medical Research Foundation · NIH-10791774 · Data updated 2026-11-12

This study is looking at whether metformin, a medication usually used for diabetes, can help people stay healthier for longer as they age, especially focusing on how insulin sensitivity might affect its benefits for those without chronic diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOklahoma Medical Research Foundation
NIH-funded
Lab location1 site (Oklahoma City, United States)
Project startSeptember 1, 2019
Project endFebruary 28, 2026
Funding year2024
Award (this year)$565,721
NIH project number5R01AG064951-05
Project IDNIH-10791774 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are free of chronic diseases and have varying levels of insulin sensitivity.

Less likely to help

Patients with existing chronic diseases or those who are not insulin sensitive may not benefit from this research.

What this research studies

This research explores the potential of metformin, a common diabetes medication, to delay aging and extend healthy lifespan. It focuses on understanding how insulin sensitivity may influence the effectiveness of metformin in individuals who are free of chronic diseases. By analyzing data from previous clinical trials, the study aims to identify which patients might benefit from metformin treatment and whether it could have negative effects on metabolic health. The research will involve human studies to clarify these relationships and guide future clinical trials.

Why it matters

Potential benefit: If successful, this research could help identify which patients can safely use metformin to potentially slow aging and improve overall health.

How similar studies have gone: Previous research has shown mixed results regarding metformin's effects on aging, indicating that this area is still being explored and holds potential for new insights.

Where this research is happening

  • Oklahoma Medical Research Foundation
    Oklahoma City, United States
    Active

Researchers

  • Principal investigator: Miller, Benjamin Francis — Oklahoma Medical Research Foundation
  • Study coordinator: Miller, Benjamin Francis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.